mckesson

McKesson Reports Fiscal 2027 Second Quarter Results and Raises Full Year Adjusted EPS Guidance

Consolidated revenues of $111.0 billion increased 8%. Earnings per diluted share of $10.44 increased $1.52. Adjusted Earnings per Diluted Share of $11.68 increased 18%. Generated $3.1 billion of cash ...
mckesson

CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health

NEW YORK, IRVING, Texas and BANNOCKBURN, Ill., October 6, 2026 — CD&R, McKesson Corporation (NYSE: MCK) (“McKesson”), and Option Care Health, Inc. (Nasdaq: OPCH) (“Option Care Health”) announced today ...
mckesson

McKesson Corporation Extends Pharmaceutical Distribution Agreement with CVS Health

IRVING, Texas, October 1, 2026—McKesson Corporation (NYSE: MCK) announced today that it has signed an agreement in principle to extend its partnership with CVS Health to distribute pharmaceuticals to ...
mckesson

McKesson Wins Vizient’s 2026 Distribution Excellence Award

In September 2026, Vizient presented McKesson with the 2026 Distribution Excellence Award at the Vizient Connections Summit in Las Vegas. The award recognizes suppliers that demonstrate superior ...
mckesson

McKesson Corporation Announces Second Quarter Fiscal 2027 Earnings Release Date

IRVING, Texas, September 23, 2026 -- McKesson Corporation (NYSE: MCK) will release its second quarter fiscal 2027 financial results after market close on Wednesday, November 4, 2026. The company will ...
mckesson

Notice of Data Breach

McKesson is investigating a cybersecurity incident involving third-party applications and unauthorized access and exfiltration of data. McKesson supplies medical equipment, pharmaceuticals, and health ...
mckesson

McKesson Signs Agreement to Acquire Precision Medicine Group, LLC

IRVING, Texas, August 25, 2026—McKesson Corporation (NYSE: MCK) announced today that it signed a definitive agreement to acquire Precision Medicine Group, LLC (“Precision Medicine Group”), a global ...
mckesson

McKesson Reports Fiscal 2027 First Quarter Results and Raises Full Year Adjusted EPS Guidance

IRVING, Texas, August 5, 2026 - McKesson Corporation (NYSE:MCK) today announced results for the first quarter ended June 30, 2026. Consolidated revenues of $105.4 billion increased 8%. Earnings per ...
mckesson

McKesson Releases Fiscal Year 2026 Impact Report

Distributing one-third of medicines with more than 99% inventory and order accuracy, strengthening advanced cancer care for patients through support of approximately 3,300 independent oncology ...
mckesson

McKesson Closes Strategic Investment with Apollo Funds for Minority Interest in Medical-Surgical Solutions

IRVING, Texas, June 2, 2026 – McKesson Corporation (NYSE: MCK) announced today the successful completion of the previously announced minority ownership interest investment from funds managed by ...
mckesson

McKesson Reports Fiscal 2026 Fourth Quarter and Full Year Results, Provides Fiscal 2027 Guidance, and Reaffirms Long-Term Financial Growth Targets

IRVING, Texas, May 7, 2026 - McKesson Corporation (NYSE:MCK) today announced results for the fourth quarter and fiscal year ended March 31, 2026. Consolidated revenues of $96.3 billion increased 6%.